Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Scientific Reports|February 12, 2021
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networksTimothy H Helms, Riley D Mullins, Jennifer M Thomas-Ahner, et al.
Molecular Pharmaceutics|May 8, 2023
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo ModelsElizabeth N Kaweesa, Jaqueline M Bazioli, Herma C Pierre, et al.
Oncotarget|April 8, 2020
Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stabilityMin-Wu Chao, Po-Chen Chu, Hsiao-Ching Chuang, et al.
Oncotarget|December 2, 2015
Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stabilityMin-Wu Chao, Po-Chen Chu, Hsiao-Ching Chuang, et al.
Molecular & Cellular Proteomics : MCP|March 25, 2026
Natural product target identification of wheldone, a fungal metabolite, as a KIF11 inhibitor in ovarian cancer using the DiffPOP (Differential Protein Precipitation) methodManead Khin, Alejandra Cavazos Saldana, Manuel Rangel-Grimaldo, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Scientific Reports|November 3, 2025
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonistGregory M Young, Timothy H Helms, Samuel K Kulp, et al.
Journal of the National Cancer Institute|October 15, 2015
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced CachexiaYu-Chou Tseng, Samuel K Kulp, I-Lu Lai, et al.
Cancer Research Communications|March 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia SusceptibilityHanieh Taheri, Yang Li, Kevin M Huang, et al.
Cancers|August 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular CarcinomaEmma J Hoelzen, Hanna S Radomska, Samuel K Kulp, et al.
Pageof 11